News
A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases like sickle ...
CRISPR Therapeutics advances with promising CTX310 data and key clinical milestones ahead. Click here to read an analysis of ...
A study has revealed that chemical tags once regarded as genetic clutter are in fact powerful gene silencers – and removing ...
A man with type 1 diabetes has produced his own insulin after receiving cell transplant, eliminating the need for ...
In the past two years, a spate of technological advances and promising results in mice have been laying the groundwork for ...
18d
Zacks Investment Research on MSNCRISPR Therapeutics to Report Q2 Earnings: What's in the Cards?
We expect investors to focus on the sales performance of CRISPR Therapeutics’ CRSP sole-marketed product, Casgevy, and other pipeline updates when the company reports its second-quarter 2025 results.
Tiny "hidden" proteins lurking in DNA once dismissed as junk may hold the key to the next generation of obesity drugs, ...
There could be new hope for people aiming to fight obesity following a research breakthrough identifying certain microproteins that store fat.In findings published in the Proceedings of the National ...
A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...
The multiagent AI system, dubbed “CRISPR-GPT,” is designed to interact and reason with human users as they execute gene-editing tasks. The model was trained using data from scientific literature, ...
Mars Inc., the confectionery, pet care, and food giant, has licensed Pairwise’s gene editing platform, called Fulcrum, to ...
Mars partners with Pairwise to use CRISPR tech for developing disease- and climate-resilient cacao, aiming to secure future ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results